Embla Medical hf Management

Management criteria checks 3/4

Embla Medical hf's CEO is Sveinn Solvason, appointed in Apr 2022, has a tenure of 2.08 years. total yearly compensation is $1.18M, comprised of 48.8% salary and 51.2% bonuses, including company stock and options. directly owns 0.016% of the company’s shares, worth DKK2.04M. The average tenure of the management team and the board of directors is 2.1 years and 15.3 years respectively.

Key information

Sveinn Solvason

Chief executive officer

US$1.2m

Total compensation

CEO salary percentage	48.8%
CEO tenure	2.1yrs
CEO ownership	0.02%
Management average tenure	2.1yrs
Board average tenure	15.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Sveinn Solvason's remuneration changed compared to Embla Medical hf's earnings?
Date	Total Compensation	Salary	Company Earnings
Mar 31 2024	n/a	n/a	US$57m
Dec 31 2023	US$1m	US$576k	US$58m
Sep 30 2023	n/a	n/a	US$52m
Jun 30 2023	n/a	n/a	US$45m
Mar 31 2023	n/a	n/a	US$43m
Dec 31 2022	US$780k	US$409k	US$43m

Compensation vs Market: Sveinn's total compensation ($USD1.18M) is below average for companies of similar size in the UK market ($USD2.33M).

Compensation vs Earnings: Sveinn's compensation has increased by more than 20% in the past year.

CEO

Sveinn Solvason (45 yo)

2.1yrs

Tenure

US$1,180,000

Compensation

Mr. Sveinn Solvason had been Chief Financial Officer of Embla Medical hf. (formerly known as ssur hf.) since May 2013 until April 1, 2022 and serves as its President & CEO since April 1, 2022.Mr. Solvaso...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Sveinn Solvason	President & CEO	2.1yrs	US$1.18m	0.016% $ 2.0m
Ossur Kristinsson	Founder	no data	US$25.00k	no data
Gudny Sveinsdottir	Chief Financial Officer	1.7yrs	no data	no data
Lukas Marklin	Chief Operating Officer	less than a year	no data	no data
Edda Luovigsdottir	Investor Relations Director	no data	no data	no data
Margret Fridriksdottir	Executive Vice President of People	no data	US$242.00k	0.0083% $ 1.1m
Olafur Gylfason	Chief Commercial Officer	no data	US$600.00k	0.0030% $ 383.0k
Gudjon Karason	Executive Vice President of EMEA & APAC	6.5yrs	no data	0.023% $ 2.9m
Christian Robinson	President of Americas	no data	no data	0.0031% $ 394.4k
Hildur Einarsdottir	Executive Vice President of Research & Development	2.1yrs	no data	0.00014% $ 17.9k

2.1yrs

Average Tenure

49yo

Average Age

Experienced Management: 0FIW's management team is considered experienced (2.1 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Niels Jacobsen	Chairman of the Board	19.3yrs	US$108.00k	0.048% $ 6.1m
Svafa Gronfeldt	Vice Chairman of the Board	16.3yrs	US$72.00k	no data
Gudbjorg Eggertsdottir	Independent Director	11.2yrs	US$43.00k	0.0062% $ 786.3k
Arne Nielsen	Director	15.3yrs	US$50.00k	no data
Alberto Esquenazi	Independent Director	3.2yrs	US$43.00k	no data

15.3yrs

Average Tenure

66yo

Average Age

Experienced Board: 0FIW's board of directors are seasoned and experienced ( 15.3 years average tenure).

Embla Medical hf Management

Management criteria checks 3/4

Key information

Recent management updates

Less than half of directors are independent

Össur hf. Appoints Caroline Vagner Rosenstand to the Audit Committee

Less than half of directors are independent

Less than half of directors are independent

Össur hf., Annual General Meeting, Mar 12, 2025

Less than half of directors are independent

Recent updates

First quarter 2024 earnings released: EPS: US$0.019 (vs US$0.024 in 1Q 2023)

Less than half of directors are independent

Össur hf. Appoints Caroline Vagner Rosenstand to the Audit Committee

Less than half of directors are independent

Investor sentiment improves as stock rises 16%

Full year 2023 earnings released: EPS: US$0.14 (vs US$0.10 in FY 2022)

Össur hf. Provides Earnings Guidance for the Year 2024

Less than half of directors are independent

Össur hf. to Report Q1, 2024 Results on Apr 23, 2024

Össur hf., Annual General Meeting, Mar 12, 2025

Less than half of directors are independent

Össur hf. Reaffirms Financial Guidance for the Year 2023

Less than half of directors are independent

Össur hf. Announces Executive Changes

First quarter 2023 earnings released: EPS: US$0.024 (vs US$0.022 in 1Q 2022)

Less than half of directors are independent

Less than half of directors are independent

Össur hf. Provides Earnings Guidance for the Year 2023

Full year 2022 earnings released

Less than half of directors are independent

Össur hf. to Report Q1, 2023 Results on Apr 25, 2023

Less than half of directors are independent

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: US$0.016 (vs US$0.041 in 3Q 2021)

Less than half of directors are independent

Össur hf. (CPSE:OSSR) acquired Naked Prosthetics.

Less than half of directors are independent

Second quarter 2022 earnings released: EPS: US$0.034 (vs US$0.046 in 2Q 2021)

Össur hf. Revises Earnings Guidance for the Year 2022

Össur hf. Reports Preliminary Earnings Results for the Second Quarter and First Half of 2022

Less than half of directors are independent

Össur Appoints Gudny Arna Sveinsdottir as Chief Financial Officer, Effective September 1, 2022

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Össur Hf. Announces New R&D Leadership

Less than half of directors are independent

Össur Launches New POWER KNEE

Össur hf. Announces Sales Guidance for the Full Year 2022

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Össur Hf. Announces Earnings Guidance for the Full Year 2021

First quarter 2021 earnings released: EPS US$0.027 (vs US$0.017 in 1Q 2020)

Össur Hf. Provides Financial Guidance for the Full Year 2021

Vice Chairman Kristján Ragnarsson has left the company

Full year 2020 earnings released: EPS US$0.015 (vs US$0.16 in FY 2019)

Revenue misses expectations

Össur hf., Annual General Meeting, Mar 08, 2022

Laboratoires Innothera S.A.S completed the acquisition of Gibaud SAS from Össur hf. (CPSE:OSSR).

Össur Hf. Withdraw Its Financial Guidance for 2020

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age